Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $389.5200 (1.25%) ($385.6200 - $395.4200) on Thu. Jul. 21, 2016. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.16% (three month average) | | RSI | 77 | | Latest Price | $389.5200(1.25%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN advances 1.3% a day on average for past five trading days. | | Weekly Trend | REGN advances 2.6% a week on average for past two weeks. | | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(62%) XLV(50%) XBI(46%) IVW(40%) IWF(40%) | | Factors Impacting REGN price | REGN will decline at least -1.08% in a week (0% probabilities).
VIXM(-9%) UUP(-7%) TLT(-7%) IPO(-6%) IBUY(-4%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.08% (StdDev 2.16%) | | Hourly BBV | 0 () | | Intraday Trend | 0.8% | | | | | |
|
| 5 Day Moving Average | $381.34(2.15%) | | 10 Day Moving Average | $376.22(3.54%) | | 20 Day Moving Average | $365.12(6.68%) | | To recent high | -4.9% | | To recent low | 17.7% | | Market Cap | $41.3b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |